A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

857

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Certolizumab Pegol

"Strength and Form: Lyophilized product reconstituted to 1 ml containing 200 mg of Certolizumab Pegol (CZP) given as a subcutaneous injection.~Dosage and Frequency: 400 mg every two weeks for at least 6 months, then 200 mg every two weeks.~Duration: Until end of study."

Trial Locations (121)

Unknown

152, Huntsville

148, San Diego

153, Danbury

133, Ocala

140, Orlando

150, Orlando

145, Sarasota

136, Tampa

157, Coeur d'Alene

155, Springfield

134, Wheaton

151, St Louis

156, Lincoln

135, Charlotte

147, Cleveland

158, Dayton

139, Charleston

137, Austin

143, San Antonio

12, Buenos Aires

14, Capital Federal

1, Capital Federal

9, Capital Federal

8, Ciudad Autonoma de Buenos Aire

11, Córdoba

2, Córdoba

13, Quilmes

7, Rosario

10, San Miguel de Tucumán

6, Santa Fe

18, Malvern

21, Maroochydore

23, Perth

179, Antwerp

199, Liège

177, Merksem

29, Pleven

221, Sofia

28, Sofia

30, Sofia

26, Stara Zagora

43, Newmarket

32, Toronto

39, Toronto

35, Hamilton

36, Kitchener

201, Pointe-Claire

31, Sainte-Foy

203, Winnipeg

190, Santiago

49, Santiago

44, Valdivia

52, Rijeka

56, Brno

57, Ostrava Trebovice

187, Pilsen

55, Prague

60, Prague

61, Prague

58, Uherské Hradiště

62, Zlín

64, Pärnu

65, Tallinn

63, Tartu

68, Hyvinkää

160, Montpellier

71, Budapest

73, Budapest

75, Bupadest

191, Debrecen

76, Miskolc

74, Szolnok

79, Afula

82, Ashkelon

81, Haifa

83, Haifa

78, Ramat Gan

77, Tel Aviv

85, Ẕerifin

86, Riga

88, Riga

92, Alytus

89, Kaunas

91, Klaipėda

93, Panevezys

90, Šiauliai

94, Vilnius

95, Mexicalli

96, Monterrey

103, Auckland

101, Christchurch

100, South Canterbury

192, Tauranga

107, Moscow

113, Moscow

222, Moscow

223, Moscow

224, Moscow

109, Saint Petersburg

111, Saint Petersburg

112, Saint Petersburg

193, Saint Petersburg

110, Yaroslavl

117, Belgrade

118, Belgrade

114, Niška Banja

115, Novi Sad

119, Bratislava

121, Košice

120, Piešťany

122, Piešťany

210, Dnipro

209, Donetsk

216, Donetsk

213, Ivano-Frankivsk

211, Kiev

212, Kiev

215, Kiev

220, Kiev

208, Symferopyl

214, Zaporizhzhya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY